|
Ocuguard Indications
Ocuguard maintains the phone line to the brain connected
In diabetic retinopathy (1-2)

Ocuguard reduces the retinopathy progression

Vitamin B12 : needed for the normal
nerve cell activity
References
- Huang SY, Jeng C, Kao SC, Yu JJ, Liu DZ. Improved
haemorrheological properties by Ginkgo biloba extract (Egb 761) in
type 2 diabetes mellitus complicated with retinopathy. Clin Nutr.
2004 Aug;23(4):615-21.
- Lanthony P, Cosson JP. The course of color vision
in early diabetic retinopathy treated with Ginkgo biloba extract.
A preliminary double-blind versus placebo study] J Fr Ophtalmol. 1988;11(10):671-4.
In age related macular degeneration
Ocuguard Reduces the risk of ARMD progression (3)
Anti oxidant
+ Zinc reduces the progression of ARMD by 25% & the risk of
visual loss by 19%

Age Related Eye Disease Study
Method
The age related eye disease study (AREDS) was a major
10 years study sponsored by the National Eye Institute (NEI) which is
a part of the National Institutes of Health (NIH) and is the U.S. government’s
lead agency for vision research. The study was conducted at 11 major
medical research centers across the nation and completed in October,
2001.
This study researched the effects of zinc and antioxidants on certain
eye conditions, including AMD. It involved 4757 participants in the
age range 55-80 years. Each Participant was given one of four treatments:
- Zinc alone
- Antioxidants alone
- Combination of zinc and antioxidants
- Placebo
Conclusion
The AREDS clearly answered a number of important questions regarding the
role antioxidants plus zinc play in maintaining ocular health. Key findings
of the AREDS include:
- Participants diagnosed with advanced cases of AMD were able to slow down the progression of the disease by about 25%, when treated with a high dose combination of vitamin C, vitamin E, beta carotene and zinc.
- Certain participants taking antioxidant plus
zinc supplements were able to reduce the risk of developing advanced AMD
by about 25%, while also reducing the risk of vision loss by
approximately 19%.
- While it was concluded that the nutrients are not a cure for AMD, the study showed that the nutrients are effective in helping to slow down the progression of the disease.
For more details on AREDS results. Visit the National Eye Institute’s
web site at www.nei.nih.go
In glaucoma
Ocuguard is an excellent Adjuvant therapy in glaucoma(4)
Glaucomatous patients have a deficiency in the blood supply to the optic nerve.
Ocuguard improves blood supply to the
optic nerve

Method
- Evaluate the possible therapeutic effects
of ginkgo biloba extract on glaucoma patients.
- No. of patients 11 healthy volunteers.
- GBE conc. 40 mg 3 times daily for 2 weeks.
Conclusion
Ginkgo biloba increases ocular blood flow velocity by 23%
Ginkgo biloba which is a powerful antioxidant, also improves microcirculation (blood flow in small blood vessels in Optic nerve) by:
- Increasing RBCs flexibility.
- Decreasing RBCs & platelet hyper
aggregation.
- Decreasing plasma & blood viscosity.
In visual fatigue
Ocuguard is a powerful antioxidant that protects ocular tissues from oxidative
stress.

Ocuguard
Indications
|